Join
Live feed
·
PRReleasevia Quantisnow
Vaxart Inc logo

Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology

ByQuantisnow·Wall Street's wire, on your screen.
VXRT· Vaxart Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VXRT (Vaxart Inc) and more on Quantisnow.